Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice

Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice

Summary In this retrospective cohort study, alendronate use among older osteoporosis patients (age>65 years) with reduced renal function (creatinine clearance

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Osteoporosis international 2021-10, Vol.32 (10), p.1981-1988
Hauptverfasser: Naganathar, N., Yau, W. -P., Mok, Z. H., Tan, Z. Y. F., Chew, S. T. H.
Format: Artikel
Sprache:eng
Schlagworte:
Adverse events
Alendronic acid
Bisphosphonates
Creatinine
Dietary supplements
Endocrinology
Fractures
Kidneys
Medicine
Medicine & Public Health
Older people
Original Article
Orthopedics
Osteoporosis
Patients
Renal function
Renal insufficiency
Rheumatology
Statistical analysis
Vitamin D
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary In this retrospective cohort study, alendronate use among older osteoporosis patients (age>65 years) with reduced renal function (creatinine clearance
ISSN:0937-941X
1433-2965
DOI:10.1007/s00198-021-05907-5